Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.
The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression.
Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells.
Once- or twice-daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach.
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.
HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.
[Position of darunavir in antiretroviral therapy].
Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption.
Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.
Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.